Navigation Links
NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
Date:11/24/2009

SAN MATEO, Calif., Nov. 24 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced the appointment of John A. Orwin to its Board of Directors, effective November 19, 2009. Mr. Orwin is a 20-year sales and marketing veteran in the biopharmaceutical industry and has been instrumental in the launch of several important therapeutics.

Mr. Orwin currently serves as Senior Vice President, BioOncology Business Unit at Genentech, Inc., a wholly-owned member of the Roche Group. In this role he is responsible for marketing, sales, business unit and late stage pipeline brand management for the largest oncology portfolio in the United States. Mr. Orwin led the successful introduction of several indications for the blockbuster products Avastin®, Rituxan®, Herceptin®, and Tarceva® in the United States. He has also served as a member of the several governance committees between Genentech and Roche, Biogen Idec, and OSI Pharmaceuticals.

From 2001 to 2004, Mr. Orwin achieved increasing responsibility at Johnson & Johnson, up to Franchise Vice President, Oncology Franchise at Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P. His previous experience includes the positions of Senior Director, Oncology Marketing at Alza Pharmaceuticals (acquired by Johnson & Johnson); Vice President, Marketing at Sangstat Medical Corporation; Marketing Director, Asthma at Rhone-Poulenc Rorer Pharmaceuticals; and Product Manager, Schering Oncology/Biotech at Schering-Plough Corporation. He led the successful launch of Taxotere in the United States while at Rhone-Poulenc Rorer and Thymoglobulin for Sangstat Medical Corporation.

Jean-Jacques Bienaime, Chairman of the NeurogesX Bo
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NeurogesX Receives FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)
2. NeurogesX Expands Commercial Operations Leadership Team
3. NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
4. NeurogesX to Present at JMP Securities Healthcare Focus Conference
5. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
6. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
7. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
8. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
9. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
10. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
11. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... (NASDAQ: CYTR ), a biopharmaceutical research and development ... the three months ended June 30, 2015, and also ... for its clinical development programs. "The second ... Enrollment in our ongoing pivotal global Phase 3 clinical ... on track to be completed in the first quarter ...
(Date:8/3/2015)... , Aug. 3, 2015 Merrimack Pharmaceuticals, ... will host its Second Quarter 2015 Investor Conference Call ...    The call will cover an update ... second quarter 2015 financials. A press release detailing the ... issued the afternoon of Monday, August 10. Investors and ...
(Date:8/3/2015)...  Celsion Corporation (NASDAQ: CLSN ) announced ... call to discuss its second quarter 2015 financial ... programs for ThermoDox®, its proprietary heat-activated liposomal encapsulation ... TheraPlas™ and TheraSilence™, in immunotherapy and RNA delivery ... 2015. To participate in the call, interested parties ...
Breaking Medicine Technology:CytRx Reports 2015 Second Quarter Financial Results 2CytRx Reports 2015 Second Quarter Financial Results 3CytRx Reports 2015 Second Quarter Financial Results 4CytRx Reports 2015 Second Quarter Financial Results 5CytRx Reports 2015 Second Quarter Financial Results 6CytRx Reports 2015 Second Quarter Financial Results 7CytRx Reports 2015 Second Quarter Financial Results 8CytRx Reports 2015 Second Quarter Financial Results 9CytRx Reports 2015 Second Quarter Financial Results 10CytRx Reports 2015 Second Quarter Financial Results 11CytRx Reports 2015 Second Quarter Financial Results 12CytRx Reports 2015 Second Quarter Financial Results 13CytRx Reports 2015 Second Quarter Financial Results 14Merrimack Pharmaceuticals Announces Timing of Second Quarter 2015 Investor Conference Call 2Celsion Corporation to Hold Second Quarter 2015 Financial Results Conference Call on Monday, August 10, 2015 2
... Nov. 17, 2010 /PRNewswire-FirstCall/ -- ... ) today announced the pricing of an underwritten public offering ... price of $4.40 per share.  The offering is expected to ... closing conditions.  In addition, AVANIR has granted the underwriters a ...
... BEIJING, Nov. 17, 2010 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, ... leading China-based advanced in-vitro diagnostic ("IVD") company, today announced ... ended September 30, 2010 ("2Q FY2010"). ... Revenues increased by 21.5% year-over-year to ...
Cached Medicine Technology:AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock 3China Medical Technologies Reports Second Fiscal Quarter Financial Results 2China Medical Technologies Reports Second Fiscal Quarter Financial Results 3China Medical Technologies Reports Second Fiscal Quarter Financial Results 4China Medical Technologies Reports Second Fiscal Quarter Financial Results 5China Medical Technologies Reports Second Fiscal Quarter Financial Results 6China Medical Technologies Reports Second Fiscal Quarter Financial Results 7China Medical Technologies Reports Second Fiscal Quarter Financial Results 8China Medical Technologies Reports Second Fiscal Quarter Financial Results 9China Medical Technologies Reports Second Fiscal Quarter Financial Results 10China Medical Technologies Reports Second Fiscal Quarter Financial Results 11China Medical Technologies Reports Second Fiscal Quarter Financial Results 12China Medical Technologies Reports Second Fiscal Quarter Financial Results 13China Medical Technologies Reports Second Fiscal Quarter Financial Results 14
(Date:8/4/2015)... Louis, MO (PRWEB) , ... August 04, 2015 ... ... attorneys handling national talcum powder lawsuits filed against Johnson & Johnson report that ... Talcum powder lawyers provide regular news updates and cancer warning information ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... digital press at its Denver facility that will usher in a new standard ... Lightning Labels more effectively meet its twin objectives of quality and ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... for executives and technology professionals in healthcare and technology markets, today announced significant ... Department of Defense’s recently-announced Electronic Health Record (EHR) decision. The DOD related numbers ...
(Date:8/3/2015)... ... August 04, 2015 , ... ... an extensive line up of live courses for the month of August. , ... courses individually or by purchasing a Physical Therapy Flex package. Flex packages ...
(Date:8/3/2015)... ... 03, 2015 , ... Zeiter’s Septic now performs septic installations ... and operated business, Zeiter’s Septic has been serving the community for over 20 ... because of their continued training and perseverance to provide their customers with new ...
Breaking Medicine News(10 mins):Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 2Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 3Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 4Health News:Lightning Labels Installs State-of-the-Art Digital Press 2Health News:Lightning Labels Installs State-of-the-Art Digital Press 3Health News:Coverage of DOD’s EHR Decision Reinforces Healthcare IT News’ Leadership 2Health News:Elite Online CE Provider Announces Schedule of Live Courses For Florida Physical Therapy Continuing Education 2Health News:Elite Online CE Provider Announces Schedule of Live Courses For Florida Physical Therapy Continuing Education 3Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 2Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 3
... San Francisco-to-Los Angeles ride May 31SAN FRANCISCO and LOS ... 41 states and 14 nations will stream out of ... Angeles as participants in the colorful and emotional AIDS/LifeCycle, ... expected to raise more than $10 million to support ...
... , , THURSDAY, May 28 (HealthDay News) -- A total ... motion in arthritic or deformed ankles has been approved ... Scandinavian Total Ankle Replacement (STAR) system is the first ... a surface of flexible plastic (polyethylene). , Total ankle ...
... PregnancyWHITE PLAINS, N.Y., May 28 Starting pregnancy at ... pregnancy is critical to giving a baby a healthy ... in response to new guidelines from the Institute of ... for the amount of weight a woman should gain ...
... in Independent CategoryNEW YORK, May 28 Prix ... development, has added a new recognition category to its 2009 ... Prix Galien USA are now being accepted at ... 1, 2009. For the first time, the Prix Galien USA ...
... Covers High-throughput, Anchorage-independent Assay for Screening Compounds for ... Falcon Genomics, Inc. announced today that it has ... the Company,s Cancer BioChip System (CBCS) for the ... a high-throughput in vitro setting with ...
... bacteria in the small intestine are both associated with ... in a new study in the June issue of ... & Sons on behalf of the American Association for ... also available online at Wiley Interscience ( www.interscience.wiley.com ). ...
Cached Medicine News:Health News:AIDS/LifeCycle 8 to Raise $10+ Million to Fight AIDS 2Health News:AIDS/LifeCycle 8 to Raise $10+ Million to Fight AIDS 3Health News:Ankle Replacement System Lets Feet Move 2Health News:New Guidelines to Fight Obesity in Pregnancy Issued 2Health News:New Guidelines to Fight Obesity in Pregnancy Issued 3Health News:Prix Galien USA Now Accepting Nominations for Premiere Biopharmaceutical Industry Award 2Health News:Falcon Genomics Awarded Patent for Innovative Cancer Test 2Health News:Intestinal bacteria associated with non-alcoholic fatty liver disease 2
Use the Mo Bio Vortex Adapter in conjunction with the Vortex Genie 2 for rapid bead beating procedures. Using the Mo Bio Vortex Adapter is an inexpensive alternative to other bead beating and Fast Pr...
... V-500 with Vacuum Controller V-800 and water-cooled secondary ... Model V-500 is a powerful ... vacuum applications. Applications Ideally suited ... Laboratory vacuum source for instruments including ...
... with Vacuum Controller V-800 Efficiently controls vacuum ... on and off as needed to maintain preset vacuum ... PTFE membrane vacuum pump designed to handle most vacuum ... with up to two rotary evaporators Laboratory ...
... BchiVac V-500 and water-cooled secondary condenser to ... a powerful PTFE membrane vacuum pump designed ... Ideally suited for use with ... Laboratory vacuum source for instruments including vacuum ...
Medicine Products: